AARDVARK THERAPEUTICS INC's (AARD) Int. Exp.: $ 0 – Insights & Market Comparison

Select company

Ticker/Company
Market Cap.

No results found

Select metric

Ticker Information

Ticker

AARD

Company Name

AARDVARK THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

AARDVARK THERAPEUTICS INC's intexpmargin vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Benchmarks

Company	intexpmargin
GALT : GALECTIN THERAPEUTICS INC	-	JBIO : JADE BIOSCIENCES INC	-	FENC : FENNEC PHARMACEUTICALS INC	0.1	OABI : OMNIAB INC	0	VNDA : VANDA PHARMACEUTICALS INC	0	ALLO : ALLOGENE THERAPEUTICS INC	-	LCTX : LINEAGE CELL THERAPEUTICS INC	0	NMRA : NEUMORA THERAPEUTICS INC	-	FDMT : 4D MOLECULAR THERAPEUTICS INC	0	LXEO : LEXEO THERAPEUTICS INC	-

Similar metrics to Revenues:

Interest Expense - [Income Statement] Interest expense is the cost incurred by a business for borrowing funds.
Research and Development Margin - [Calculation] The company’s research and development expenses [RnD] expressed as a percentage of [Revenue].
Stock Based Compensation Margin - [Calculation] The company’s stock-based compensation [SbComp] expressed as a percentage of [Revenue].
Operating Cash Flow Margin - [Calculation] The company's operating cash flow [NCFO] expressed as a percentage of [Revenue].
Depreciation and Amortization Margin - [Calculation] The company’s deprecation and amortization [DepAmor] expressed as a percentage of [Revenue].

Definition of

Benchmark Analysis
Market

The chart above depicts the distribution of for companies in the Total Stock Market. The average of the companies is 0.02 with a standard deviation of 0.02.

The following table provides additional summary stats:

undefined in the Market:

filtered constituents	3.15K
min	-0.05
max	0.08
average	0.02
median	0.01
std	0.02